105 related articles for article (PubMed ID: 24978311)
1. Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer.
Xue X; Liu F; Han Y; Li P; Yuan B; Wang X; Chen Y; Kuang Y; Zhi Q; Zhao H
Biochem Biophys Res Commun; 2014 Jul; 450(2):1058-62. PubMed ID: 24978311
[TBL] [Abstract][Full Text] [Related]
2. [Expression of circadian gene NPAS2 in colorectal cancer and its prognostic significance].
Yang SF; Xu M; Yang HY; Li PQ; Chi XF
Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):714-8. PubMed ID: 27222192
[TBL] [Abstract][Full Text] [Related]
3. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response.
Hoffman AE; Zheng T; Ba Y; Zhu Y
Mol Cancer Res; 2008 Sep; 6(9):1461-8. PubMed ID: 18819933
[TBL] [Abstract][Full Text] [Related]
4. NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A.
Yuan P; Li J; Zhou F; Huang Q; Zhang J; Guo X; Lyu Z; Zhang H; Xing J
Cell Death Dis; 2017 Mar; 8(3):e2704. PubMed ID: 28333141
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer.
Liu M; Zhi Q; Wang W; Zhang Q; Fang T; Ma Q
Biomed Pharmacother; 2015 Feb; 69():214-20. PubMed ID: 25661360
[TBL] [Abstract][Full Text] [Related]
6. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
[TBL] [Abstract][Full Text] [Related]
7. Parafibromin expression is an independent prognostic factor for colorectal carcinomas.
Zheng HC; Wei ZL; Xu XY; Nie XC; Yang X; Takahashi H; Takano Y
Hum Pathol; 2011 Aug; 42(8):1089-102. PubMed ID: 21315421
[TBL] [Abstract][Full Text] [Related]
8. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
Yi C; Mu L; de la Longrais IA; Sochirca O; Arisio R; Yu H; Hoffman AE; Zhu Y; Katsaro D
Breast Cancer Res Treat; 2010 Apr; 120(3):663-9. PubMed ID: 19649706
[TBL] [Abstract][Full Text] [Related]
9. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
10. Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis.
Tang JQ; Fan Q; Wu WH; Jia ZC; Li H; Yang YM; Liu YC; Wan YL
Chin Med J (Engl); 2010 Dec; 123(24):3559-65. PubMed ID: 22166631
[TBL] [Abstract][Full Text] [Related]
11. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling.
Ma S; Chen Y; Quan P; Zhang J; Han S; Wang G; Qi R; Zhang X; Wang F; Yuan J; Yang X; Jia W; Qin W
BMC Cancer; 2023 Mar; 23(1):280. PubMed ID: 36978001
[TBL] [Abstract][Full Text] [Related]
12. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
13. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
15. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells.
Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
Cancer Lett; 2020 Jan; 469():498-509. PubMed ID: 31765736
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.
Dong W; Li H; Zhang Y; Yang H; Guo M; Li L; Liu T
Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):840-8. PubMed ID: 21968416
[TBL] [Abstract][Full Text] [Related]
17. Neuronal PAS Domain 2 (Npas2)-Deficient Fibroblasts Accelerate Skin Wound Healing and Dermal Collagen Reconstruction.
Sasaki H; Hokugo A; Wang L; Morinaga K; Ngo JT; Okawa H; Nishimura I
Anat Rec (Hoboken); 2020 Jun; 303(6):1630-1641. PubMed ID: 30851151
[TBL] [Abstract][Full Text] [Related]
18. High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study.
Cao XM; Kang WD; Xia TH; Yuan SB; Guo CA; Wang WJ; Liu HB
World J Gastroenterol; 2023 Jun; 29(23):3645-3657. PubMed ID: 37398880
[TBL] [Abstract][Full Text] [Related]
19. Spectroscopic and DNA-binding characterization of the isolated heme-bound basic helix-loop-helix-PAS-A domain of neuronal PAS protein 2 (NPAS2), a transcription activator protein associated with circadian rhythms.
Mukaiyama Y; Uchida T; Sato E; Sasaki A; Sato Y; Igarashi J; Kurokawa H; Sagami I; Kitagawa T; Shimizu T
FEBS J; 2006 Jun; 273(11):2528-39. PubMed ID: 16704425
[TBL] [Abstract][Full Text] [Related]
20. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
